CHI3L1 and small cell lung carcinoma: Both non-small-cell lung carcinoma (NSCLC) and small-cell lung carcinoma (SCLC) patients have been reported to show high CHI3L1 expression and serum levels, and these have been reported to be associated with poorer overall survival.